The current ACL market cap is 494.49M. The company's latest EPS is AUD 0.1779 and P/E is 13.77.
Year End June 29 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 519.47M | 0 | 644.67M | 997.17M | 704.76M |
Operating Income | 47.31M | 0 | 108.55M | 266.6M | 61.99M |
Net Income | 41.26M | 0 | 60.37M | 178.24M | 35.9M |
Year End June 29 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 366.05M | 406.7M | 484.1M | 628.04M | 578.91M |
Total Liabilities | 297.07M | 359.6M | 402.19M | 395.49M | 406.24M |
Total Equity | 68.99M | 47.1M | 81.91M | 232.56M | 172.67M |
Year End June 29 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | 101.74M | N/A | 153.86M | 284.09M | 143.68M |
Investing | -9.96M | N/A | -6.08M | -72.04M | -12.18M |
Financing | -60.92M | N/A | -147.37M | -220.91M | -137.88M |
Market Cap | 494.49M |
Price to Earnings Ratio | 13.77 |
Price to Sales Ratio | 0.7 |
Price to Cash Ratio | 24.77 |
Price to Book Ratio | 2.86 |
Dividend Yield | - |
Shares Outstanding | 201.83M |
Average Volume (1 week) | 401.25k |
Average Volume (1 Month) | 947.06k |
52 Week Change | -26.87% |
52 Week High | 3.53 |
52 Week Low | 2.14 |
Spread (Intraday) | 0.03 (1.21%) |
Company Name | Australian Clinical Labs Limited |
Address |
1868-1892 dandenong road melbourne, victoria 3168 |
Website | https://clinicallabs.com.au/offer |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.